Antifungal activity of the essential oil of Eugenia caryophyllata on Candida tropicalis strains from clinical isolates;Actividad antifúngica del aceite esencial de Eugenia caryophyllata sobre cepas de Candida tropicalis de aislados clínicos

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 11, Issue 3, 2012, Pages 208-217

  Moura Mendes, Juliana ^a   Sarmento Guerra, Felipe Queiroga ^a   de Oliveira Pereira, Fillipe ^a   Pereira de Sousa, Janiere ^a   Nogueira Trajano, Vinicius ^a   de Oliveira Lima, Edeltrudes ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Antifungal activity; Candida tropicalis; Candidiasis; Clinical isolates; Clove; Essential oil; Strong activity

Indexed keywords

AMPHOTERICIN B; ESSENTIAL OIL;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA TROPICALIS; CINNAMOMUM ZEYLANICUM; CLOVE; CONCENTRATION RESPONSE; DISK DIFFUSION; FUNGAL STRAIN; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OREGANO;

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; CINNAMOMUM VERUM; ORIGANUM VULGARE; SYZYGIUM AROMATICUM;

EID: 84861779334     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Adams RP. 2001. Identification of essential oils components by gas chromatogram-phy/quadrupole mass spectroscopy. Allured Publishing Corporation, Illinois, USA.
2. Alma MH, Ertaş M, Nitz S, Kollmannsberger H. 2007. Chemical composition of content of essential oil from the bud of cultivated Turkish Clove. Bio Res 2: 265-269.
3. Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A. 2005. Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43: 1829-1835.
4. Alqareer A, Alyahya A, Andersson L. 2006. The effect of clove and benzocaine versus placebo as topical anesthetics. J Dent 34: 747-750.
5. Antunes AG, Pasqualotto AC, Diaz MC, D'Azevedo PA, Severo LC. 2004. Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns. Rev Inst Med Trop 46: 239-241.
6. Arango ACM, Sánchez JGB, Galvis LAB. 2004. Productos naturales con actividad antimicótica. Rev Esp Quimioter 17: 325-331.
7. Ayoola GA, Lawore FM, Adelowotan T, Aibinu IE, Adenipekun E, Coker HAB, Odugbemi TO. 2008. Chemical analysis and antimicrobial activity of the essential oil of Syzigium aromaticum (clove). Afr J Microbiol Res 2: 162-166.
8. Bansod S, Rai M. 2008. Antifungal Activity of Essential Oils from Indian Medicinal Plants Against Human Pathogenic Aspergillus fumigatus and A. niger. World J Med Sci 3: 81-88.
9. Baydarh H, Sagdiç O, Ozkan G. 2004. Antibacterial activity and composition of essential oils from Origanum, Thymbra and Satureja species with commercial importance in Turkey. Food Control 15: 169-172
10. Bruder-Nascimento A, Camargo CH, Sugizaki MF, Sadatsune T, Montelli AC, Mondelli AL, Bagagli E. 2010. Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital. BMC Res Notes 3: 1-5.
11. Burt S. 2004. Essential oils: their antibacterial properties and potential applications in foods-a review. Int J Food Microbiol 94: 223-253.
12. Burt SA, Reinders RD. 2003. Antibacterial activity of selected plant essential oils against Escherichia coli O157:H7. Lett Appl Microbiol 36: 162-167.
13. Busatta C, Mossi AJ, Rodrigues MRA, Cansian RL, Oliveira JV. 2007. Evaluation of Origanum vulgare essential oil as antimicrobial agent in sausage. Braz J Microbiol 38: 610-616.
14. Castro RD, Lima EO. 2010. Atividade antifúngica in vitro do óleo essencial de Eucalyptus globulus L. sobre Candida spp. Rev Odontol UNESP 39: 179-184.
15. Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi, AB, Rouabhia M, Mahdouani K, Bakhrouf A. 2007. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): A short review. Phytother Res 21: 501-506.
16. Cheng MF, Yang YL, Yao TJ, Lin CY, Liu JS, Tang RB, Yu KW, Fan YH, Hsieh KS, Ho M, Lo HJ. 2005. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 5: 1-5.
17. Colombo AL, Guimarães T. 2003. Epidemiologia das infecções hematogênicas por Candida spp. Rev Soc Bras Med Trop 36: 599-607.
18. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, Da Matta DA, Warnock D, Morgan J. for the Brazilian Network Candidemia Study. 2006. Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers. J Clin Microbiol 44: 2816-2823.
19. Correa-Royero J, Tangarife V, Durán C, Stashenko E, Mesa-Arango A. 2010. In vitro antifungal activity and cytotoxic effect of essential oils and extracts of medicinal and aromatic plants against Candida krusei and Aspergillus fumigatus. Braz J Pharmacogn 20: 734-741.
20. Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 88: 170-175.
21. Daniel NA, Sartoretto SM, Schmidt G, Caparroz-Assef SM, Bersani-Amado CA, Cuman RKN. 2009. Anti-inflammatory and antinociceptive activities of eugenol essential oil in experimental animal models. Rev Bras Farmacogn 19: 212-217.
22. Ellof JN. 1998. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64: 711-713.
23. Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA. 1999. In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Mycology 33: 75-80.
24. Friedman M, Henika PR, Mandrell RE. 2002. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J Food Prot 65: 1545-1560.
25. Fu YJ, Zu YG, Chen LY, Shi XG, Wang Z, Sun S, Efferth T. 2007. Antimicrobial Activity of Clove and Rosemary Essential Oils Alone and in Combination. Phytother Res 21: 989-994.
26. Gayoso CW, Lima EO, Olivera VT, Pereira FO, Souza EL, Lima EL, Navarro DF. 2005. Sensitivity of fungi isolated from onichomicosis to Eugenia caryophyllata essential oil and eugenol. Fitoterapia 76: 247-249.
27. Giordani R, Regli P, Kaloustian J, Mikaïl C, Abou L, Portugal H. 2004. Antifungal Effect of Various Essential Oils against Candida albicans. Potentiation of Antifungal Action of Amphotericin B by Essential Oil from Thymus vulgaris. Phytother Res 18: 990-995.
28. Godoy P, Tiraboschi IN, Severo LC, Bustamante B, Calvo B, Da Matta DA, Colombo AL. 2003. Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals. Mem Inst Oswaldo Cruz 98: 401-405.
29. Hadacek F, Greger H. 2000. Testing of antifungical natural products: methodologies, comparability of results and assay choise. Phytoch Anal 11: 137-147.
30. Hood JR, Wilkinson JM, Cavanagh HMA. 2003. Evaluation of common antibacterial screening methods utilized in essential oil research. J Essent Oil Res 15: 428-433.
31. Klepser ME, Ernst EJ, Ernst ME, Messer SA, Pfaller MA. 1998. Evaluation of endpoints for antifungal susceptibility determinations with LY303366. Antimicrob Agents Chemother 42: 1387-1391.
32. Kouidhi B, Zmantar T, Bakhrouf A. 2010. Anticariogenic and cytotoxic activity of clove essential oil (Eugenia caryophyllata) against a large number of oral pathogens. Ann Microbiol 60: 599-604.
33. Lambert RJW, Skandamis PN, Coote PJ. 2001. A study of the minimum inhibitory concentration and mode of action of oregano esssencial oil, thymol and carvacrol. J Appl Microbiol 91: 453-462.
34. Lima EO, Gompertz OF, Giesbrecht AM, Paulo MQ. 1993. In vitro antifungal activity of essential oils obtained from officinal plants against dermatophytes. Mycoses 36: 333-336.
35. Lima IO, Oliveira RAG, Lima EO, Farias NMP, Souza EL. 2006. Atividade antifúngica de óleos essenciais sobre espécies de Candida. Rev Bras Farmacogn 16: 197-201.
36. Milind P, Deepa K. 2011. Clove: A Champion Spice. Int J Res Ayurveda Pharm 2: 47-54.
37. Miyazawa M, Hisama M. Suppression of chemical mutagen induced SOS response by alkylphenols from clove (Syzygium aromaticum) in the Salmonella typhimurium TA1535/pSK1002 umu test. J Agric Food Chem 49: 4019-4025.
38. Nascimento PFC, Nascimento AC, Rodrigues CS, Antoniolli AR, Santos PO, Júnior AMB, Trindade RC. 2007. Atividade antimicrobiana dos óleos essenciais: uma abordagem multifatorial dos métodos. Rev Bras Farmacogn 17: 108-113.
39. Nucci M, Colombo AL. 2007. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58: 77-82.
40. Nucci, M.; Silveira, M. I.; Spector, N.; Silveira, F.; Velasco, E.; Martins, C. A.; Derossi, A.; Colombo, A. L.; Pulcheri, W. 1998. Fungemia in cancer patients in Brazil: predominance of non-albicans species. Mycopathologia 141: 65-68.
41. Nzeako BC, Al-Kharousi ZSN, Al-Mahrooqui Z. 2006. Antimicrobial Activities of Clove and Thyme Extracts. Sultan Qaboos Univ Med J 6: 33-39.
42. Nzeako BC, Lawati BA. 2008. Comparative studies of antimycotic potential of thyme and clove oil extracts with antifungal antibiotics on Candida albicans. Afr J Biotechnol 7: 1612-1619.
43. Pereira FO, Wanderley PA, Viana FAC, Lima RB, Sousa FB, Santos SG, Lima EO. 2011. Effects of Cymbopogon winterianus Jowitt ex Bor essential oil on the growth and morphogenesis of Trichophyton mentagrophytes. Braz J Pharm Sci 47: 145-153.
44. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ. 2000. Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 44: 747-751.
45. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. 2009. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Clin Microbiol 58: 1454-1462.
46. Prashar A, Locke IC, Evans, CS. 2006. Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells. Cell Prolif 39: 241-242.
47. Rates SMK. 2001. Plants as source of drugs. Toxicon 39: 603-613.
48. Saad A, Fadli M, Bouaziz M, Benharref A, Mezrioui N-E, Hassani L. 2010. Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol. Phytomedicine 17: 1057-1060.
49. Sartoratto A, Machado ALM, Delarmelina C, Figueira GM, Duarte MCT, Rehder VLG. 2004. Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Braz J Microbiol 35: 275-280.
50. Schmid RA. 1972. resolution of the Eugenia-Syzygium controversy (Myrtaceae). Am J Bot 59: 423-436.
51. Schofield DA, Westwater C, Paulling EE, Nicholas PJ, Balish E. 2003. Detection of Candida albicans mRNA from formalin-fixed, paraffin-embedded, mouse tissues by nested reverse transcription-PCR. J Clin Microbiol 41: 831-834.
52. Scorzoni L, Benaducci T, Almeida AMF, Silva DHS, Bolzani VS, Mendes-Giannini MJS. 2007. Comparative study of disk diffusion and microdilution methods for evaluation of antifungal activity of natural compounds against medical yeasts Candida spp. and Cryptococcus sp. Rev Ciênc Farm Básica Apl 28: 25-34.
53. Shinobu CS, Ogatta SFY, Bizerra F, Furlaneto L, Peralta RM, Svidzinski TIE, Consolaro MEL. 2007. Lack of Association Between Genotypes and Virulence Factors in C. albicans Strains Isolated From Vaginal Secretion. Braz J Microbiol 38: 467-471.
54. Souza EL, Stamford TLM, Lima EO, Trajano VN. 2007. Effectiveness of Origanum vulgare L. essential oil to inhibit the growth of food spoiling yeasts. Food Control 18: 409-413.
55. Tavanti A, Pardini G, Campa D, Davini P, Lupetti A, Senesi S. 2004. Differential Expression of Secretory Aspartyl Proteinase Genes (SAP1-10) in Oral Candida albicans Isolates with Distinct Karyotypes. J Clin Microbiol 42: 4726-4734.
56. Vinsonneau C, Benyamina M, Baixench MT, Stephanazzi J, Augris C, Grabar S, Paugam A, Wassermann D. 2009. Effects of candidaemia on outcome of burns. Burns 35: 561-564.
57. Wingard JR. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20: 115-125.
58. Wroblewska MM, Swoboda-Kopec E, Rokosz A, Krawczyk E, Marchel H, Luczak M. 2002. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles. Int J Antimicrob Ag 20: 472-475.
59. Zaugg C, Zepelin MBV, Reichard U, Sanglard D, Monod M. 2001. Secreted Aspartic Proteinase Family of Candida tropicalis. Infect Immun 69: 405-412.